 <h1>Solifenacin Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of solifenacin include:</b> constipation and xerostomia. <b>Other side effects include:</b> urinary tract infection and blurred vision.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to solifenacin: oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, solifenacin may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking solifenacin:</p><p>
<i>More common</i>
</p><ul>
<li>Constipation</li>
<li>stomach pain</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Bladder pain</li>
<li>bloody or cloudy urine</li>
<li>blurred vision</li>
<li>chills</li>
<li>decrease in the frequency of urination</li>
<li>decrease in urine volume</li>
<li>difficult, burning, or painful urination</li>
<li>dizziness</li>
<li>dry eyes</li>
<li>fever</li>
<li>frequent urge to urinate</li>
<li>headache</li>
<li>lower back or side pain</li>
<li>nervousness</li>
<li>pounding in the ears</li>
<li>slow or fast heartbeat</li>
<li>swelling of the lower legs</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>body aches or pain</li>
<li>chest pain or discomfort</li>
<li>confusion</li>
<li>cough</li>
<li>decreased or increased sweating</li>
<li>diarrhea</li>
<li>discouragement</li>
<li>dry skin</li>
<li>fainting</li>
<li>feeling sad or empty</li>
<li>general feeling of discomfort or illness</li>
<li>hives or welts, itching, skin rash</li>
<li>hoarseness</li>
<li>irregular heartbeat recurrent</li>
<li>irritability</li>
<li>joint pain</li>
<li>lack of appetite</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs</li>
<li>loss of interest or pleasure</li>
<li>muscle aches and pains</li>
<li>redness of the skin</li>
<li>runny or stuffy nose</li>
<li>seeing, hearing, or feeling things that are not there</li>
<li>shivering</li>
<li>sore throat</li>
<li>tender, swollen glands in the neck</li>
<li>tingling of the hands or feet</li>
<li>trouble concentrating</li>
<li>trouble with sleeping</li>
<li>trouble with swallowing</li>
<li>unusual weight gain or loss</li>
<li>voice changes</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of solifenacin may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Dry mouth</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>belching</li>
<li>heartburn</li>
<li>indigestion</li>
<li>nausea</li>
<li>stomach discomfort or upset</li>
<li>vomiting</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to solifenacin: oral tablet</i></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Dry mouth (up to 28%), constipation (up to 13%)</p>
<p><b>Common</b> (1% to 10%): Nausea, dyspepsia, upper abdominal pain, vomiting</p>
<p><b>Uncommon</b> (0.1% to 1%): Gastroesophageal reflux disease, dry throat, flatulence, throat irritation, eructation, thirst</p>
<p><b>Rare</b> (less than 0.1%): Colonic obstruction, fecal impaction </p>
<p><b>Postmarketing reports</b>: Ileus<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pharyngitis, cough, sinusitis, bronchitis</p>
<p><b>Uncommon</b> (0.1% to 1%): Nasal dryness </p>
<p><b>Postmarketing reports</b>: Dysphonia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression</p>
<p><b>Postmarketing reports</b>: Confusion, hallucinations, delirium, somnolence<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Blurred vision, dry eyes</p>
<p><b>Very rare</b> (less than 0.01%): Glaucoma<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection, urinary retention</p>
<p><b>Uncommon</b> (0.1% to 1%): Cystitis, suprapubic pain, bladder pain, micturition urgency<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Lower limb edema, hypertension</p>
<p><b>Uncommon</b> (0.1% to 1%): Syncope, chest tightness, hot flushes</p>
<p><b>Postmarketing reports</b>: Peripheral edema, QT prolongation, Torsade de Pointes, atrial fibrillation, tachycardia, palpitations, atrial fibrillation<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Dry skin</p>
<p><b>Rare</b> (0.01% to 0.1%): Pruritus, rash </p>
<p><b>Very rare</b> (less than 0.01%): Erythema multiforme, urticaria, angioedema, exfoliative dermatitis<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very rare</b> (less than 0.01%): Decreased appetite, hyperkalemia<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Very rare</b> (less than 0.01%): Hypersensitivity reactions (including angioedema with airway obstruction, rash, pruritus, urticaria, and anaphylactic reaction)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very rare</b> (less than 0.01%): Renal impairment<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Postmarketing reports</b>: Abnormal liver function tests, AST (aspartate aminotransferase), ALT (alanine aminotransferase), GGT (gamma-glutamyl transferase)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia, back pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Neck pain</p>
<p><b>Postmarketing reports</b>: Muscular weakness<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, insomnia</p>
<p><b>Uncommon</b> (0.1% to 1%): Dysgeusia</p>
<p><b>Rare</b> (0.01% to 0.1%): Headache </p>
<p><b>Postmarketing reports</b>: Headache, tremors<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. VESIcare (solifenacin)." GlaxoSmithKline, Research Triangle Park, NC. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about solifenacin</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>161 Reviews</li>
<li>Drug class: urinary antispasmodics</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Solifenacin &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>VESIcare, VESIcare LS</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Overactive Bladder</li>
<li>Neurogenic Bladder</li>
<li>Urinary Frequency</li>
<li>Urinary Incontinence</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to solifenacin: oral tablet</i></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Dry mouth (up to 28%), constipation (up to 13%)</p><p><b>Common</b> (1% to 10%): Nausea, dyspepsia, upper abdominal pain, vomiting</p><p><b>Uncommon</b> (0.1% to 1%): Gastroesophageal reflux disease, dry throat, flatulence, throat irritation, eructation, thirst</p><p><b>Rare</b> (less than 0.1%): Colonic obstruction, fecal impaction </p><p><b>Postmarketing reports</b>: Ileus<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pharyngitis, cough, sinusitis, bronchitis</p><p><b>Uncommon</b> (0.1% to 1%): Nasal dryness </p><p><b>Postmarketing reports</b>: Dysphonia<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression</p><p><b>Postmarketing reports</b>: Confusion, hallucinations, delirium, somnolence<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Blurred vision, dry eyes</p><p><b>Very rare</b> (less than 0.01%): Glaucoma<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection, urinary retention</p><p><b>Uncommon</b> (0.1% to 1%): Cystitis, suprapubic pain, bladder pain, micturition urgency<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Lower limb edema, hypertension</p><p><b>Uncommon</b> (0.1% to 1%): Syncope, chest tightness, hot flushes</p><p><b>Postmarketing reports</b>: Peripheral edema, QT prolongation, Torsade de Pointes, atrial fibrillation, tachycardia, palpitations, atrial fibrillation<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Dry skin</p><p><b>Rare</b> (0.01% to 0.1%): Pruritus, rash </p><p><b>Very rare</b> (less than 0.01%): Erythema multiforme, urticaria, angioedema, exfoliative dermatitis<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very rare</b> (less than 0.01%): Decreased appetite, hyperkalemia<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Very rare</b> (less than 0.01%): Hypersensitivity reactions (including angioedema with airway obstruction, rash, pruritus, urticaria, and anaphylactic reaction)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very rare</b> (less than 0.01%): Renal impairment<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Postmarketing reports</b>: Abnormal liver function tests, AST (aspartate aminotransferase), ALT (alanine aminotransferase), GGT (gamma-glutamyl transferase)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia, back pain</p><p><b>Uncommon</b> (0.1% to 1%): Neck pain</p><p><b>Postmarketing reports</b>: Muscular weakness<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, insomnia</p><p><b>Uncommon</b> (0.1% to 1%): Dysgeusia</p><p><b>Rare</b> (0.01% to 0.1%): Headache </p><p><b>Postmarketing reports</b>: Headache, tremors<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. VESIcare (solifenacin)." GlaxoSmithKline, Research Triangle Park, NC. </p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2>More about solifenacin</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>161 Reviews</li>
<li>Drug class: urinary antispasmodics</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Solifenacin &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Overactive Bladder</li>
<li>Neurogenic Bladder</li>
<li>Urinary Frequency</li>
<li>Urinary Incontinence</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>